Team:HKUST-Hong Kong/Module

From 2012.igem.org

(Difference between revisions)
Line 326: Line 326:
           <div id="paragraph2" class="bodyParagraphs">
           <div id="paragraph2" class="bodyParagraphs">
           <div align="left">
           <div align="left">
-
               <h1><p align=center>Anti-tumor Molecule Secretion</p></h1>
+
               <h1><p align=center>Anti-tumor Molecule Secretion Module</p></h1>
           </div>
           </div>
           <p>As our team objective is to provide a specific and efficient drug for Colon cancer, the way of drug synthesis and releasing is a significant part of our whole project. Hence this module is focusing on the production and delivery of anti-tumor drug......<a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Anti_tumor">click to see more</a></p>
           <p>As our team objective is to provide a specific and efficient drug for Colon cancer, the way of drug synthesis and releasing is a significant part of our whole project. Hence this module is focusing on the production and delivery of anti-tumor drug......<a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Module/Anti_tumor">click to see more</a></p>

Revision as of 16:31, 24 September 2012

Team:HKUST-Hong Kong - 2012.igem.org

MODULE

Target Binding Module

YOURWIKITEXT

Anti-tumor Molecule Secretion Module

As our team objective is to provide a specific and efficient drug for Colon cancer, the way of drug synthesis and releasing is a significant part of our whole project. Hence this module is focusing on the production and delivery of anti-tumor drug......click to see more

Regulation and Control Module

Our module aims at regulating our synthetic bacteria B. hercules. We first introduce a xylose inducible promoter, which can help us control the timing of BMP-2 expression. Our choice of xylose as an inducer stems from its induction efficiency, its little existence and low absorption rate in colon......click here to see more